Acid-suppressive medications in the first year of life and risk of childhood asthma: a population-based birth cohort study
- 4 June 2020
- journal article
- letter
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 56 (5), 2000197
- https://doi.org/10.1183/13993003.00197-2020
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Maintenance therapy with proton pump inhibitors and risk of gastric cancer: a nationwide population-based cohort study in SwedenBMJ Open, 2017
- The role of the gut microbiota in food allergyCurrent Opinion in Pediatrics, 2016
- Acid suppression therapy and allergic reactionsAllergo Journal, 2015
- Acid suppression therapy and allergic reactionsAllergo Journal International, 2015
- Gastroesophageal Reflux Disease Increases Infant Acute Respiratory Illness Severity, but not Childhood AsthmaPediatric Allergy, Immunology, and Pulmonology, 2014
- International consensus on (ICON) pediatric asthmaAllergy, 2012
- Early life antibiotic‐driven changes in microbiota enhance susceptibility to allergic asthmaEMBO Reports, 2012
- Childhood Asthma: Diagnosis and TreatmentScientifica, 2012
- Gastroesophageal Reflux and Asthma in Children: A Systematic ReviewPEDIATRICS, 2010
- Suppression of gastric acid increases the risk of developing Immunoglobulin E‐mediated drug hypersensitivity: human diclofenac sensitization and a murine sensitization modelClinical & Experimental Allergy, 2010